Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial.

Abstract:

:Insulin resistance (IR) is reportedly involved in the progression of hepatocellular carcinoma (HCC). Since neovascularization plays an important role in hepatocarcinogenesis and IR, an angiostatic therapy may be considered as one of the promising approaches for chemoprevention against HCC. The aim of the current study was to examine the combination effect of a clinically used branched-chain amino acid (BCAA) and an angiotensin-converting enzyme inhibitor (ACE-I), both reportedly possess anti-angiogenic and IR-improving activities, on the cumulative recurrence after curative therapy. BCAA granules (Livact; 12 g/day) and/or ACE-I (perindopril; 4 mg/day) were administered after the curative therapy for HCC, and several indices were analyzed. A 48-month follow-up revealed that the combination treatment with BCAA and ACE-I markedly inhibited the cumulative recurrence of HCC under IR conditions, whereas neither single treatment exerted a significant inhibition. The soluble form of the vascular endothelial growth factor (VEGF; a central angiogenic factor) receptor-2 (sVEGFR2) was significantly decreased only three months after the treatment without recurrence. We also observed that IR, determined by the homeostasis model assessment (HOMA-IR), was significantly improved by this regimen, indicating that an inhibitory effect was achieved, at least partly, by coordinated effects of anti-angiogenesis and IR improvement. In conclusion, since both BCAA and ACE-I are widely used in clinical practice with safety, this combination therapy may represent a potential new strategy for chemoprevention against IR-based HCC recurrence in the future. Moreover, sVEGFR2 may become a useful clinical predictive marker of this combination treatment.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Yoshiji H,Noguchi R,Ikenaka Y,Kaji K,Aihara Y,Yamazaki M,Yamao J,Toyohara M,Mitoro A,Sawai M,Yoshida M,Morioka C,Fujimoto M,Uemura M,Fukui H

doi

10.3892/or.2011.1433

subject

Has Abstract

pub_date

2011-12-01 00:00:00

pages

1547-53

issue

6

eissn

1021-335X

issn

1791-2431

journal_volume

26

pub_type

杂志文章,随机对照试验
  • Pentoxifylline inhibits perforin-dependent natural cytotoxicity in vitro.

    abstract::Pentoxifylline (PTX) is commonly used in peripheral blood vessel diseases, however it has also been found to decrease the level of proinflammatory cytokines such as IL-12, TNF-alpha and IFN-gamma. Moreover, some authors reported that PTX suppresses spontaneous cytotoxicity of peripheral blood mononuclear cells (PBMC) ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.9.2.423

    authors: Lazarczyk M,Grzela T,Korczak-Kowalska G,Niderla J,Oldak M,Jozwiak J,Skopinski P

    更新日期:2002-03-01 00:00:00

  • Leukemia inhibitory factor receptor negatively regulates the metastasis of pancreatic cancer cells in vitro and in vivo.

    abstract::Pancreatic cancer (PC) is one of the leading causes of cancer-related deaths worldwide. Frequent metastasis and recurrence are the main reasons for the poor prognosis of PC patients. Thus, the discovery of new biomarkers and wider insights into the mechanisms involved in pancreatic tumorigenesis and metastasis is cruc...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4865

    authors: Ma D,Jing X,Shen B,Liu X,Cheng X,Wang B,Fu Z,Peng C,Qiu W

    更新日期:2016-08-01 00:00:00

  • Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cells.

    abstract::Apoptosis is a crucial event for anticancer drug efficacy. The signal pathways activated by anticancer drugs are classified as death receptor (DR) -dependent or -independent. The mechanisms by which anticancer drugs induce apoptosis via DR-dependent pathways are not fully understood. In the present study, we assessed ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kim R,Tanabe K,Emi M,Uchida Y,Toge T

    更新日期:2003-11-01 00:00:00

  • CHAF1B promotes proliferation and reduces apoptosis in 95‑D lung cancer cells and predicts a poor prognosis in non‑small cell lung cancer.

    abstract::Chromatin assembly factor 1 subunit B (CHAF1B) participates in DNA synthesis and repair. High CHAF1B expression has been associated with a poor prognosis in several types of cancers. However, no study has evaluated the clinical significance and biological function of CHAF1B in non‑small cell lung cancer (NSCLC). In th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.6994

    authors: Duan Y,Liu T,Li S,Huang M,Li X,Zhao H,Li J

    更新日期:2019-04-01 00:00:00

  • PBOV1 correlates with progression of ovarian cancer and inhibits proliferation of ovarian cancer cells.

    abstract::Prostate and breast cancer overexpressed 1 (PBOV1) is significantly upregulated in prostate, breast and bladder cancer, while its expression status in ovarian cancer and its clinical significance are unclear. We examined the expression levels of PBOV1 mRNA and protein in ovarian cancer cell lines and primary tissues u...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4396

    authors: Wang L,Niu CH,Wu S,Wu HM,Ouyang F,He M,He SY

    更新日期:2016-01-01 00:00:00

  • Growth inhibition and apoptosis of human B-cell lymphoma in vitro and in vivo by Bcl-2 short hairpin RNA.

    abstract::Bcl-2 is overexpressed in various types of human tumors, including Burkitt's lymphoma, and it is involved in tumorigenesis and chemoresistance, therefore, it is regarded as a potential target of gene therapy. In this study, RNA interference using short hairpin RNA (shRNA)-mediated R...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2081

    authors: Liu Y,Shen Y,Qin C,Shi Y,Rong G,Yu X

    更新日期:2013-01-01 00:00:00

  • Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma.

    abstract::Single nucleotide polymorphisms (SNPs) in the p53, MDM2 and p21 genes of the p53 pathway have been extensively studied. The main aim of the current retrospective study was to evaluate the possible predictive value of SNPs in the p53 pathway in locoregionally advanced nasopharyngeal carcinoma (NPC) in response to radio...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2808

    authors: Xie X,Jin H,Hu J,Zeng Y,Zhou J,Ouyang S,Yang W,Hu B,Wang H

    更新日期:2014-01-01 00:00:00

  • Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells.

    abstract::Progesterone has a potential protective effect against ovarian carcinoma induced by estrogen. Progesterone is also known to cause apoptosis while tamoxifen induces growth arrest. Therefore, we attempted to determine whether combined treatment with progesterone and tamoxifen has a sy...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1460

    authors: Lee JY,Shin JY,Kim HS,Heo JI,Kho YJ,Kang HJ,Park SH,Lee JY

    更新日期:2012-01-01 00:00:00

  • Tissue-specific regulation of Apaf-1 expression by p53.

    abstract::The p53 tumor suppressor is a transcription factor that regulates cell cycle and apoptosis in response to a variety of environmental stress conditions. Recent studies indicated that the apoptotic protease activating factor-1 (Apaf-1) is a direct transcriptional target of p53 in DNA damage-induced apoptosis. However, t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Ho CK,Bush JA,Li G

    更新日期:2003-09-01 00:00:00

  • Serum HE4 levels combined with CE CT imaging improve the management of monitoring women affected by epithelial ovarian cancer.

    abstract::The aim of the present study was to evaluate human epididymis protein 4 (HE4) as a marker of epithelial ovarian cancer (EOC) relapse and the combination of this biomarker with contrast-enhanced high-resolution multidetector row computed tomography CE CT imaging to impove the monitoring of EOC patients. Twenty-one pati...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2682

    authors: Manganaro L,Michienzi S,Vinci V,Falzarano R,Saldari M,Granato T,Viggiani V,Frati L,Anastasi E

    更新日期:2013-11-01 00:00:00

  • Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.

    abstract::The characteristics of ovarian cancers that showed low activation of glycolysis were investigated. Using medical records of patients with ovarian cancers who had undergone fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) prior to their primary surgery at the University of Tokyo Hospital...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5398

    authors: Sato M,Kawana K,Adachi K,Fujimoto A,Taguchi A,Fujikawa T,Yoshida M,Nakamura H,Nishida H,Inoue T,Ogishima J,Eguchi S,Yamashita A,Tomio K,Arimoto T,Wada-Hiraike O,Oda K,Nagamatsu T,Osuga Y,Fujii T

    更新日期:2017-03-01 00:00:00

  • Terrein inhibits migration of human breast cancer cells via inhibition of the Rho and Rac signaling pathways.

    abstract::Breast cancer is the most common cancer in women worldwide. Progression and aggressiveness of breast cancer is usually associated with its migration and invasion abilities. Recently, natural products with potential anticancer activity have become attractive candidates for alternative treatment of cancer. A fungal meta...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6189

    authors: Kasorn A,Loison F,Kangsamaksin T,Jongrungruangchok S,Ponglikitmongkol M

    更新日期:2018-03-01 00:00:00

  • Calphostin C, a remarkable multimodal photodynamic killer of neoplastic cells by selective nuclear lamin B1 destruction and apoptogenesis (Review).

    abstract::Perylenequinones that generate reactive oxygen species (ROS) when illuminated with visible light have been recommended as photodynamic chemotherapeutic agents. One of these is calphostin C (CalC), the action of the photo-activated derivative of which, CalCphiE, has been ascribed to its ability to selectively and irrev...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or_00000711

    authors: Chiarini A,Whitfield JF,Pacchiana R,Marconi M,Armato U,Dal Prà I

    更新日期:2010-04-01 00:00:00

  • ERAP140/Nbla10993 is a novel favorable prognostic indicator for neuroblastoma induced in response to retinoic acid.

    abstract::In the present study, we identified a gene termed Nbla10993 whose expression levels are higher in favorable neuroblastomas versus unfavorable ones. Structural analysis showed that Nbla10993 is a novel splicing variant of the ER-associated protein of 140 kDa (ERAP140), which lacks the central acidic as well as the COOH...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Arai H,Ozaki T,Niizuma H,Nakamura Y,Ohira M,Takano K,Matsumoto M,Nakagawara A

    更新日期:2008-06-01 00:00:00

  • Rab15 alternative splicing is altered in spheres of neuroblastoma cells.

    abstract::Neuroblastoma is an aggressive pediatric tumor that accounts for 15% of cancer-related deaths in children. More than half of high-risk neuroblastoma patients develop tumor relapse that is lethal in most cases. A small population of tumor-initiating cells (TICs), recently identified from high-risk neuroblastoma patient...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1731

    authors: Pham TV,Hartomo TB,Lee MJ,Hasegawa D,Ishida T,Kawasaki K,Kosaka Y,Yamamoto T,Morikawa S,Yamamoto N,Kubokawa I,Mori T,Yanai T,Hayakawa A,Takeshima Y,Iijima K,Matsuo M,Nishio H,Nishimura N

    更新日期:2012-06-01 00:00:00

  • Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF‑κB signaling pathway.

    abstract::Breast cancer which is the most common type of diagnosed cancer among women worldwide possesses metastatic potential, multi‑drug resistance, and high mortality. The NF‑κB signaling pathway has been revealed to be abnormally activated in breast cancer cells and closely associated with high metastasis and poor prognosis...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7891

    authors: Zeng A,Liang X,Zhu S,Liu C,Wang S,Zhang Q,Zhao J,Song L

    更新日期:2020-12-09 00:00:00

  • Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma.

    abstract::Peroxiredoxin 1 (Prdx1) is an antioxidant and plays an important role in H2O2-mediated cell signaling. We previously found that the expression level of Prdx1 was elevated in esophagus squamous cell carcinoma (ESCC) tissue using a proteomics approach. Since overexpressed protein can induce an autoimmune response, to fu...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2714

    authors: Ren P,Ye H,Dai L,Liu M,Liu X,Chai Y,Shao Q,Li Y,Lei N,Peng B,Yao W,Zhang J

    更新日期:2013-11-01 00:00:00

  • Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer.

    abstract::Cancer represents a significant challenge for humankind, as early diagnosis and treatment are difficult to achieve. To systemically investigate the effect of sex, body mass index (BMI) and age on cancer incidence and prognosis, the data from 14,504 cases of cancer were downloaded from The Cancer Genome Atlas (TCGA). B...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6529

    authors: Huang X,Shu C,Chen L,Yao B

    更新日期:2018-09-01 00:00:00

  • 18F-fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts.

    abstract::We investigated whether 18F-fluorothymidine-positron-emission tomography/computed tomography (18F-FLT-PET/CT) is useful for the evaluation of the very early response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab therapy in human lung cancer xenografts. A human tumor xenograft model was established...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1338

    authors: Takeuchi S,Zhao S,Kuge Y,Zhao Y,Nishijima K,Hatano T,Shimizu Y,Kinoshita I,Tamaki N,Dosaka-Akita H

    更新日期:2011-09-01 00:00:00

  • Recombinant hirudin suppresses the viability, adhesion, migration and invasion of Hep-2 human laryngeal cancer cells.

    abstract::Recombinant hirudin (rH) is a highly potent and specific inhibitor of thrombin, and has been shown to inhibit the growth and metastasis of several types of cancers in experimental tumor models. The objective of this study was to evaluate the antitumor effects and explore the underlying mechanisms of rH in Hep-2 human ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3717

    authors: Lu Q,Lv M,Xu E,Shao F,Feng Y,Yang J,Shi L

    更新日期:2015-03-01 00:00:00

  • Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells.

    abstract::Currently, there are emerging multiple studies on human epididymis protein 4 (HE4) in ovarian cancer. HE4 possesses higher sensitivity and specificity than CA125 in the confirmative early diagnosis for ovarian cancer. Although much attention has been given to explore its clinical application, research of the basic mec...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4926

    authors: Zhu L,Guo Q,Jin S,Feng H,Zhuang H,Liu C,Tan M,Liu J,Li X,Lin B

    更新日期:2016-09-01 00:00:00

  • Inhibition of autophagy enhances the targeted therapeutic effect of sorafenib in thyroid cancer.

    abstract::The multi-target kinase inhibitor sorafenib has been approved for the treatment of patients with advanced differentiated thyroid cancer. However, different sensitivities to sorafenib have been observed, and few patients have benefited from sorafenib treatment in the long term. In the event of acquired resistance to so...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.6118

    authors: Yi H,Ye T,Ge M,Yang M,Zhang L,Jin S,Ye X,Long B,Li L

    更新日期:2018-02-01 00:00:00

  • Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: a study based on SWOG protocol S0420.

    abstract::To evaluate the prognostic values of different protein expression in the progression of squamous cell carcinoma of the head and neck (SCCHN) patients, we conducted immunohistochemical (IHC) analysis in tissue samples of different patients enrolled on SWOG protocol S0420. S0420 was a phase II trial to evaluate the effi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2374

    authors: Mehta S,Moon J,Hashmi M,Leblanc M,Huang CH,Rinehart E,Wolf GT,Urba SG,Banerjee SK,Williamson S

    更新日期:2013-06-01 00:00:00

  • Fingolimod sensitizes EGFR wild‑type non‑small cell lung cancer cells to lapatinib or sorafenib and induces cell cycle arrest.

    abstract::Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase and mutations in this gene are major drivers of lung cancer development. EGFR tyrosine kinase inhibitors (TKIs) are standard first‑line therapies for patients with advanced non‑small cell lung cancer (NSCLC) with activating EGFR mutations, but are n...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7140

    authors: Ota K,Okuma T,Lorenzo A,Yokota A,Hino H,Kazama H,Moriya S,Takano N,Hiramoto M,Miyazawa K

    更新日期:2019-07-01 00:00:00

  • Enhancement of DNA cancer vaccine efficacy by combination with anti-angiogenesis in regression of established subcutaneous B16 melanoma.

    abstract::Immunotherapy of cancer offers great promise, however translation into human studies has yielded relatively poor results to date. The concept of combining cancer vaccination with angiogenesis inhibition is appealing, due to favorable safety profile of both approaches, as well as possible biological synergies. Here we ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000555

    authors: Chan RC,Gutierrez B,Ichim TE,Lin F

    更新日期:2009-11-01 00:00:00

  • Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.

    abstract::Patient survival in pancreatic cancer remains poor with gemcitabine (GEM)-based regimens. The target specific molecular agent lapatinib, a dual ErbB1 and ErbB2 receptor tyrosine kinase inhibitor, has shown significant activity against ErbB1 and ErbB2-expressing tumors. Since pancrea...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2053

    authors: Singla S,Pippin JA,Drebin JA

    更新日期:2012-12-01 00:00:00

  • Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer.

    abstract::The effects of a novel oral fluoropyrimidine derivative S-1 on peritoneal metastasis from gastric cancer were investigated. OCUM-2MD3 cells, a highly peritoneal-metastatic cell line, were injected intraperitoneally in nude mice. These mice were allocated to the following three groups (each group, n=10): the S-1 group,...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yamagata S,Nakata B,Hirakawa K

    更新日期:2004-11-01 00:00:00

  • Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.

    abstract::Hypoxic tumor cells are known to be more resistant to conventional chemotherapy and radiation than normoxic cells. However, the effects of 2-methoxyestradiol (2-ME), an anti-angiogenic, antiproliferative and pro-apoptotic drug, on hypoxic lung cancer cells are unknown. The aim of the present study was to compare the e...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4399

    authors: Aquino-Gálvez A,González-Ávila G,Delgado-Tello J,Castillejos-López M,Mendoza-Milla C,Zúñiga J,Checa M,Maldonado-Martínez HA,Trinidad-López A,Cisneros J,Torres-Espíndola LM,Hernández-Jiménez C,Sommer B,Cabello-Gutiérrez C,Guti

    更新日期:2016-01-01 00:00:00

  • Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers.

    abstract::Neuroblastoma is a tumor accounting for approximately 10% of all childhood malignancies and 50% of all childhood cancer-related deaths. MYCN gene copy number variation represents the most important prognostic factor in neuroblastoma. Prognostic significance of MYCN gene expression is more complicated and may depend on...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2383

    authors: Prochazka P,Hrabeta J,Vicha A,Cipro S,Stejskalova E,Musil Z,Vodicka P,Eckschlager T

    更新日期:2013-06-01 00:00:00

  • MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.

    abstract::Evidence has shown that microRNAs play important roles in tumor development, progression, and metastasis. miR-128 has been reported to be deregulated in different tumor types, whereas the function of miR-128 in colorectal carcinoma (CRC) largely remains to be elucidated. The aim of the present study was to investigate...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4251

    authors: Wu L,Shi B,Huang K,Fan G

    更新日期:2015-11-01 00:00:00